64 citations
- InsermFR4 papers
- Université Paris CitéFR4 papers
- Délégation Paris 7FR3 papers
- Assistance Publique – Hôpitaux de ParisFR2 papers
- Centre National de la Recherche ScientifiqueFR2 papers
- Hôpital Bichat-Claude-BernardFR2 papers
- Sorbonne Paris CitéFR2 papers
- Aarhus UniversityDK1 paper
- Centre de Recherche Médecine, Sciences, Santé, Santé Mentale, SociétéFR1 paper
- Centre d'Immunologie et des Maladies InfectieusesFR1 paper
- Da Volterra (France)FR1 paper
- Flame UniversityIN1 paper
Showing 2017 · q-bio.QMShow all
2 papers · 2 filters
q-bio.QM2017★ 64 cited
Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review
Paul Loubet, Charles Burdet, William Vindrios +6
Anti-staphylococcal penicillins (ASPs) are recommended as first-line agents in methicillin-susceptible Staphylococcus aureus (MSSA) bacteraemia. Concerns about their safety profile…
q-bio.QM2017★ 24 cited
Protection of hamsters from mortality by reducing fecal moxifloxacin concentration with DAV131A in a model of moxifloxacin-induced Clostridium difficile colitis
Charles Burdet, Sakina Sayah-Jeanne, Thu Thuy Nguyen +7
BackgroundLowering the gut exposure to antibiotics during treatments can prevent microbiota disruption. We evaluated the effect of an activated charcoal-based adsorbent, DAV131A, o…